Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders

Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders

US Patent 11752155 · Granted Sep 12, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Brace for ladder2025
Carm1 inhibitors and uses thereof2023
Arginine methyltransferase inhibitors and uses thereof2022
Arginine methyltransferase inhibitors and uses thereof2021
3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor an2021
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiet2021
Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiet2021
Arginine methyltransferase inhibitors and uses thereof2020
Arginine methyltransferase inhibitors and uses thereof2020
CARM1 inhibitors and uses thereof2020
3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor an2020
Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists2019